Startup Fundraising

UK Tech Funding Roundup: AI, Health, Green Tech Deals

Explore recent UK tech funding rounds totaling over £166M. Discover investments in AI, healthtech, fintech, and cleantech sectors.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Artificial Intelligence (AI), Healthcare, Healthtech & Medtech in United Kingdom" are published.

Key Takeaways

  • Partly raised a new round from DST Global Partners, Johnson & Johnson Innovation – JJDC, BGF, Cambridge Innovation Capital, AVP, Lowercarbon Capital, Plural, Mercia Ventures, Tees River, Daphni, Blast Club, Speedinvest, Playfair Capital, Altum Capital Management, Engine Ventures, 2150, PXN Ventures (via the GMC Life Sciences Fund), Northern Gritstone, Empirical Ventures, ACF Investors, Future Planet Capital (via the UK Innovation and Science Seed Fund), NPIF II – PXN Equity Finance, SCVC (Science Creates), Deep Science Ventures, Cambridge Enterprise VC, Puma Growth Partners, Enterprise Ireland.
  • Sector: Artificial Intelligence (AI), Healthcare, Healthtech & Medtech, Financial Services & Fintech, Technology, Software & Gaming, Green Mobility, Cleantech & Climatech.
  • Geography: United Kingdom.

Analysis

The United Kingdom's technology sector is demonstrating robust investor confidence, with recent funding rounds totaling over £166 million across nine distinct companies. This significant influx of capital, representing a nearly 50% increase from the previous week, highlights a dynamic market environment where innovation in artificial intelligence, healthcare, and sustainable technologies is particularly drawing attention.

Leading the charge is Partly, an AI firm focused on revolutionizing the automotive aftermarket. The London-based company secured a substantial £38 million in Series B funding from DST Global Partners. Partly's proprietary Interpreter AI model aims to streamline inefficiencies within the collision repair supply chain, a sector ripe for digital transformation. This investment underscores the growing appetite for AI solutions that address complex operational challenges in traditional industries.

The life sciences and health tech arenas also saw significant backing. Trimtech Therapeutics, a Cambridge-based biotech startup, garnered £35.6 million in seed funding from a notable syndicate including Johnson & Johnson Innovation – JJDC, BGF, and Cambridge Innovation Capital. Their focus on developing targeted protein degraders for neurodegenerative diseases, with an emphasis on crossing the blood-brain barrier, positions them at the forefront of advanced therapeutic research. Similarly, Astral Systems, based in Bristol, raised £23 million in Series A funding for its innovative modular fusion reactors designed for producing critical medical radioisotopes. Investors in this round include Mercia Ventures, Tees River, Daphni, Blast Club, Speedinvest, and Playfair Capital.

Sustainability and decarbonization efforts are also attracting considerable investment. Isometric, another London-based entity, closed a £30 million Series A round led by AVP, with participation from Lowercarbon Capital, Plural, and several angel investors. Isometric's automated verification platform, Certify, employs AI to validate carbon removal and sustainability claims, addressing a critical need for transparency in the green economy. In the electric vehicle space, Superlight received £15.9 million in Series A funding from Engine Ventures and 2150 for its specialized commercial electric vehicles designed for logistics, leveraging aerospace engineering principles.

Further bolstering the health tech sector, Silveray secured £5 million. This Stockport-based company develops advanced X-ray film technology for industrial testing and medical imaging. The investment came from a diverse group of investors including PXN Ventures (via the GMC Life Sciences Fund), Northern Gritstone, Empirical Ventures, ACF Investors, Future Planet Capital (via the UK Innovation and Science Seed Fund), and NPIF II – PXN Equity Finance. Additionally, Cambridge-based Houdini Bio, a university spinout, raised £1.5 million in pre-seed funding from SCVC (Science Creates), Deep Science Ventures, and Cambridge Enterprise VC for its AI-driven approach to designing therapeutic DNA sequences.

Rounding out the week's deals is equipal, a fintech company that raised £16.25 million from Altum Capital Management for its embedded point-of-sale financing platform for B2B vendors. In the HR tech space, HR Duo secured £1.4 million from Puma Growth Partners and Enterprise Ireland to enhance its integrated platform for managing shift work, time tracking, and compliance for SMEs.